Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | SCN1A | P35498 | 1/20 | 0.36 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.36 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18633195 | 0.89 | ALDH1A1 (0.50) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL9150800 | 0.88 | CYP3A4 (0.53) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL30927115 | 0.83 | CYP3A4 (0.56) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL28727085 | 0.83 | KMT2A (0.41) | CYP3A4ALDH1A1MEN1KMT2ACYP2D6 | |
| SCHEMBL9678088 | 0.83 | CYP3A4 (0.56) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL6065166 | 0.82 | CYP3A4 (0.71) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL9148130 | 0.80 | CYP3A4 (0.53) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL1276072 | 0.80 | CYP3A4 (0.49) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL30927087 | 0.78 | CYP3A4 (0.73) | CYP3A4ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL128215 | 0.78 | CYP3A4 (0.73) | CYP3A4ALDH1A1TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140127275-A1 | Composition Containing a Cellulose Derived Capsule With A Sunscreen | CoLabs International Corporation (US) | 2014-05-08 | — | — | US | claimed |
| US-20110008272-A1 | Use of Creatine or Creatine Compounds for Skin Preservation | AVICENA GROUP, INC. (US) | 2011-01-13 | — | — | US | claimed |
| US-20050186158-A1 | Use of creatine or creatine compounds for skin preservation | AVICENA GROUP, INC. (US) | 2005-08-25 | — | — | US | claimed |
| US-11957769-B2 | Polyhydroxy fullerene sunscreen active agents and compositions | THE CLEVELAND CLINIC FOUNDATION (US) | 2024-04-16 | — | — | US | disclosed |
| EP-3411008-B1 | COMPOSITIONS COMPRISING POLYHYDROXY FULLERENE SUNSCREEN ACTIVE AGENTS | CLEVELAND CLINIC FOUND (US) | 2023-05-17 | — | — | EP | disclosed |
| US-11166885-B2 | Personal care gel and method | COLGATE-PALMOLIVE COMPANY (US) | 2021-11-09 | — | — | US | disclosed |
| EP-3506873-B1 | PERSONAL CARE GEL AND METHOD | COLGATE PALMOLIVE CO (US) | 2021-11-03 | — | — | EP | disclosed |
| US-20210251860-A1 | POLYHYDROXY FULLERENE SUNSCREEN ACTIVE AGENTS AND COMPOSITIONS | CLEVELAND CLINIC FOUND (US) | 2021-08-19 | — | — | US | disclosed |
| US-10925817-B2 | Polyhydroxy fullerene sunscreen active agents and compositions | THE CLEVELAND CLINIC FOUNDATION (US) | 2021-02-23 | — | — | US | disclosed |
| US-10842728-B2 | Light-absorbing compositions and methods of use | ALLELE BIOTECHNOLOGY & PHARMACEUTICALS, INC. (US) | 2020-11-24 | — | — | US | disclosed |
| EP-3672520-A1 | LIGHT-ABSORBING COMPOSITIONS AND METHODS OF USE | Allele Biotechnology And Pharmaceuticals, Inc. (US) | 2020-07-01 | — | — | EP | disclosed |
| US-20070269526-A1 | Carotenoid Composition and Method for Preparation Thereof | BOS MICHAEL A | 2007-11-22 | — | — | US | disclosed |
| US-7226582-B2 | Sunscreen compositions and methods of use | AQUEA SCIENTIFIC CORPORATION (US) | 2007-06-05 | — | — | US | disclosed |
| US-20060210497-A1 | Novel resorcinol derivatives | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2006-09-21 | — | — | US | disclosed |
| US-20060188458-A1 | Sunscreen compositions and methods of use | COLABS INTL CORP | 2006-08-24 | — | — | US | disclosed |
| US-20060188462-A1 | Skin care compositions containing a sugar amine | BISSETT DONALD L | 2006-08-24 | — | — | US | disclosed |
| US-20060182699-A1 | Personal care compositions containing hydrophobically modified non-platelet particles | PROCTER & GAMBLE COMPANY | 2006-08-17 | — | — | US | disclosed |
| US-20050123575-A1 | Spreadable compositions for topical use, an improved process of making same and methods of using same | PERRIGO ISRAEL PHARMACEUTICALS LTD. (IL) | 2005-06-09 | — | — | US | disclosed |
| US-5993787-A | COMBINING WITH PROPYLENE CARBONATE AND GLYCEROL A SHORT CHAIN ALCOHOL OR GLYCOL IN AN AMOUNT SUFFICIENT TO EFFECTUATE MISCIBILITY BETWEEN SAID PROPYLENE CARBONATE AND SAID GLYCEROL. | JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. (US) | 1999-11-30 | — | — | US | disclosed |
| US-5605894-A | A MIXTURE OF SALICYLIC ACID, A SUNSCEEN, ANTIINFLAMMATORY AGENT, VITAMIN, ANTIOXIDANT, CHELATOR, RETINOID, A BENZUFURAN, AN N-ACETYL-L-CYSTEINE AND A SKIN PROTECTANT; NONTOXIC | RICHARDSON-VICKS INC. (US) | 1997-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110008272-A1 | Use of Creatine or Creatine Compounds for Skin Preservation | PC, CKMT1A; CKMT1B, CHEK1 | CYP3A4 1581/4885ALDH1A1 2904/4885TSHR 3321/4885 |
| US-20140127275-A1 | Composition Containing a Cellulose Derived Capsule With A Sunscreen | MSH6, TYR, CUTA | CYP3A4 1425/4885ALDH1A1 854/4885TSHR 4315/4885 |
| US-20060210497-A1 | Novel resorcinol derivatives | NR1H2, DEGS1, NR1H3 | CYP3A4 489/4885ALDH1A1 1426/4885TSHR 2496/4885 |
| US-20060188462-A1 | Skin care compositions containing a sugar amine | RBP4, RBP1, RARB | CYP3A4 2189/4885ALDH1A1 1370/4885TSHR 747/4885 |
| US-11166885-B2 | Personal care gel and method | CUTA, GLMN, ISG15 | CYP3A4 4760/4885ALDH1A1 2002/4885TSHR 3463/4885 |
| US-20050186158-A1 | Use of creatine or creatine compounds for skin preservation | PC, CKMT1A; CKMT1B, CHEK1 | CYP3A4 1581/4885ALDH1A1 2904/4885TSHR 3321/4885 |
| US-10842728-B2 | Light-absorbing compositions and methods of use | CYBA, BROX, S100A6 | CYP3A4 4851/4885ALDH1A1 2131/4885TSHR 4644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.